KalVista Pharmaceuticals (KALV) Revenue (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) Revenue (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 354.55% |
| Apr 30, 2020 | 142.49% |
| Jan 31, 2020 | -59.77% |
| Oct 31, 2019 | 16.36% |
| Jul 31, 2019 | 15.14% |
| Apr 30, 2019 | -24.78% |
| Jan 31, 2019 | -30.44% |
| Oct 31, 2018 | 50.40% |
| Jul 31, 2018 | -23.18% |
| Apr 30, 2018 | 107.64% |
| Jan 31, 2018 | 106.83% |
| Oct 31, 2017 | 1,073.96% |
| Jul 31, 2017 | -15.79% |
| Apr 30, 2017 | -54.03% |
| Jan 31, 2017 | 25.89% |
| Oct 31, 2016 | -79.79% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.00% |